Rezultati - Perry Mohammed

Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial od Anna Maria Geretti, Mathe Moeketsi, Ralph Demasi, Yvon van Delft, Perry Mohammed

Polni tekst

Associations between exposure to the U=U message and perceived HIV stigma among both the HIV and non-HIV adult populations in South Africa od Sibongile Kubheka, Rickesh Patel, Pholokgolo Ramothwala, Michelle Moorhouse, Perry Mohammed, Andres Doblado-Maldonado, Chinyere Okoli

Polni tekst

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV od Paula Munderi, Edwin Were, Anchalee Avihingsanon, Pascale A.M Mbida, Lerato Mohapi, Samba B. Moussa, Marjolein Jansen, Ceyhun Bicer, Perry Mohammed, Yvon van Delft

Polni tekst

Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locat... od Cassidy A. Gutner PhD, Marc van der Valk MD, PhD, Joaquin Portilla MD, Eliette Jeanmaire MD, Leïla Belkhir MD, PhD, Thomas Lutz MD, Rebecca DeMoor MSc, Rekha Trehan BSc, Jenny Scherzer MBA, MSc, Miguel Pascual-Bernáldez PharmB, Mounir Ait-Khaled PhD, Beatriz Hernandez PharmD, PhD, Annemiek de Ruiter MBBS, FRCP, Savita Bakhshi Anand PhD, Emma L. Low PhD, Monica Hadi PhD, Nicola Barnes MA, Nick Sevdalis PhD, Perry Mohammed MBBS, Maggie Czarnogorski MD, MPH

Polni tekst